Zymar and Breastfeeding
No research has been conducted on Zymar (gatifloxacin) and breastfeeding, so it's unknown if the drug passes through breast milk. If your healthcare provider recommends this medicine while breastfeeding, you can reduce the amount that may reach the breast milk by applying gentle pressure to the tear duct with your finger for at least one minute after applying Zymar to the eye.
Zymar® (gatifloxacin) is a prescription eye drop used to treat bacterial conjunctivitis (commonly called "pink eye"). It belongs to the fluoroquinolone group of medications.
At this time, it is unknown if this medication passes through breast milk. Therefore, if you are breastfeeding a child, you should talk with your healthcare provider about using Zymar.
No research has been done to see if Zymar passes through breast milk. The active ingredient in Zymar, gatifloxacin, is known to pass through the breast milk of rats; however, it is unknown if it passes through human breast milk. Based on the properties of the medication, it is expected to do so.
Zymar is an eye drop, and very little of the medicine is expected to reach the bloodstream after normal use. Therefore, it is unlikely that the drug would reach the breast milk or the nursing infant. However, because Zymar has never been studied in breastfeeding women, all potential problems cannot yet be ruled out.
To help reduce the amount of Zymar that may reach the breast milk, apply gentle pressure to the tear duct with your finger for at least one minute after using it. Then gently wipe away any remaining medication with a tissue.
You should discuss breastfeeding and Zymar with your healthcare provider. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision that is right for you.